Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eyal David

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
Immunity|May 4, 2021
Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulationAdelle P McFarland, Adam Yalin, Shuang-Yin Wang, et al.
Nature Immunology|May 20, 2018
Re-evaluating microglia expression profiles using RiboTag and cell isolation strategiesZhana Haimon, Alon Volaski, Johannes Orthgiess, et al.
European Journal of Immunology|April 27, 2018
Microglial MHC class II is dispensable for experimental autoimmune encephalomyelitis and cuprizone-induced demyelinationYochai Wolf, Anat Shemer, Liron Levy-Efrati, et al.
Cancer Cell|January 23, 2026
Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cellsGal Yagel, Dana Rimini, Michelle von Locquenghien, et al.
Nature Biotechnology|March 11, 2020
Dissecting cellular crosstalk by sequencing physically interacting cellsAmir Giladi, Merav Cohen, Chiara Medaglia, et al.
Nature Cancer|October 27, 2022
Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signalingIdo Yofe, Tomer Landsberger, Adam Yalin, et al.
Science Immunology|June 16, 2019
IL-23-producing IL-10Rα-deficient gut macrophages elicit an IL-22-driven proinflammatory epithelial cell responseBiana Bernshtein, Caterina Curato, Marianna Ioannou, et al.
The Journal of Experimental Medicine|March 24, 2017
Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammationYochai Wolf, Anat Shemer, Michal Polonsky, et al.
Nature Cancer|November 14, 2022
Author Correction: Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signalingIdo Yofe, Tomer Landsberger, Adam Yalin, et al.
Cell|June 2, 2020
Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 PatientsPierre Bost, Amir Giladi, Yang Liu, et al.
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
Immunity|May 4, 2021
Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulationAdelle P McFarland, Adam Yalin, Shuang-Yin Wang, et al.
Nature Immunology|May 20, 2018
Re-evaluating microglia expression profiles using RiboTag and cell isolation strategiesZhana Haimon, Alon Volaski, Johannes Orthgiess, et al.
European Journal of Immunology|April 27, 2018
Microglial MHC class II is dispensable for experimental autoimmune encephalomyelitis and cuprizone-induced demyelinationYochai Wolf, Anat Shemer, Liron Levy-Efrati, et al.
Cancer Cell|January 23, 2026
Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cellsGal Yagel, Dana Rimini, Michelle von Locquenghien, et al.
Nature Biotechnology|March 11, 2020
Dissecting cellular crosstalk by sequencing physically interacting cellsAmir Giladi, Merav Cohen, Chiara Medaglia, et al.
Nature Cancer|October 27, 2022
Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signalingIdo Yofe, Tomer Landsberger, Adam Yalin, et al.
Science Immunology|June 16, 2019
IL-23-producing IL-10Rα-deficient gut macrophages elicit an IL-22-driven proinflammatory epithelial cell responseBiana Bernshtein, Caterina Curato, Marianna Ioannou, et al.
The Journal of Experimental Medicine|March 24, 2017
Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammationYochai Wolf, Anat Shemer, Michal Polonsky, et al.
Nature Cancer|November 14, 2022
Author Correction: Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signalingIdo Yofe, Tomer Landsberger, Adam Yalin, et al.
Cell|June 2, 2020
Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 PatientsPierre Bost, Amir Giladi, Yang Liu, et al.
Pageof 10